Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD

About this episode

Dr. Anikó Sijs-Szabó and Roger Mulet Lázaro, PhD, discuss the complexities of diagnosing and treating acute leukemias of ambiguous lineage.

Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD, join Dr. Charles de Bock to unpack the challenges of diagnosing and treating acute leukemias of ambiguous lineage (ALAL). Discover how RNA sequencing, machine learning, and collaboration are shaping the future of precision medicine in hematology. 🎧 Listen and then read the full open-access article on the HemaSphere website https://bit.ly/4oeJo6w

People in this episode

Host: Dr. Charles de Bock

Guests: Dr. Anikó Sijs-Szabó, Roger Mulet Lázaro, PhD

Topics covered

• acute leukemia
• precision medicine
• RNA sequencing
• machine learning
• hematology

Keywords

• leukemia
• transcriptomics
• diagnosis
• treatment
• healthcare
• collaboration
• machine learning

Mentioned in this episode

Organizations: HemaSphere

More episodes of HemaSphere Podcast

• Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood · February 9, 2026 · 47 min
• Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate · December 2, 2025 · 55 min
• EHA/EBMT Survey on Grading and Management of ICAHT - Dr Kai Rejeski · October 1, 2025 · 41 min
• Tackling NUP98 Rearranged AML in Pediatric Oncology - Prof Michel Zwaan, Prof Olaf Heidenreich · September 1, 2025 · 41 min
• Part 2 - Metabolism in hematology - Ep 3.4 · July 29, 2025 · 29 min
• Part 1 - Metabolism in hematology - Ep 3.4 · July 29, 2025 · 30 min